about
Clinical applications of choroidal imaging technologiesVisual function assessment in simulated real-life situations in HIV-infected subjects.12-month results of the standardised combination therapy for diabetic macular oedema: intravitreal bevacizumab and navigated retinal photocoagulationChoroidal abnormalities detected by near-infrared reflectance imaging as a new diagnostic criterion for neurofibromatosis 1.Visual function assessment in simulated real-life situations in patients with age-related macular degeneration compared to normal subjects.Safety and efficacy of oral fluorescein angiography in detecting macular edema in comparison with spectral-domain optical coherence tomography.Impact on intraocular pressure after 20-mg decanted triamcinolone acetonide (kenalog) injection when using prophylactic antiglaucoma therapy.A novel navigated laser system brings new efficacy to the treatment of retinovascular disordersThe spectrum of ocular alterations in patients with β-thalassemia syndromes suggests a pathology similar to pseudoxanthoma elasticum.Multimodal imaging in deferoxamine retinopathy.One-year outcomes of aflibercept in recurrent or persistent neovascular age-related macular degeneration.Influence of scanning density on macular choroidal volume measurement using spectral-domain optical coherence tomographyCombined depth imaging technique on spectral-domain optical coherence tomography.Temporal pattern of resolution/recurrence of choroidal neovascularization during bevacizumab therapy for wet age-related macular degeneration.Outer retinal tubulations response to anti-VEGF treatment.Functional and Structural Abnormalities in Deferoxamine Retinopathy: A Review of the Literature.Combined depth imaging using optical coherence tomography as a novel imaging technique to visualize vitreoretinal choroidal structures.Choroidal volume variations during childhood.Concurrent primary vitreoretinal and spinal cord lymphoma: a unique entity.Early panretinal abnormalities on fundus autofluorescence and spectral domain optical coherence tomography after intravitreal ocriplasmin.Correlation of spectral domain optical coherence tomography characteristics with visual acuity in eyes with subfoveal scarring after treatment for wet age-related macular degeneration.Fundus autofluorescence and optical coherence tomography findings in pigmented paravenous retinochoroidal atrophy.Comet lesions in pseudoxanthoma elasticum: a spectral domain optical coherence tomography analysis.Visual phenomena perceived during pars plana vitrectomy under peribulbar block and monitored anaesthesia care.Neurodegeneration in Type 2 Diabetes: Evidence From Spectral-Domain Optical Coherence Tomography.Significance of the hyperautofluorescent ring associated with choroidal neovascularisation in eyes undergoing anti-VEGF therapy for wet age-related macular degeneration.Optical coherence tomography findings of the vitreoretinal interface in asymptomatic fellow eyes of patients with acute posterior vitreous detachment.In vivo evaluation of retinal ganglion cells degeneration in eyes with branch retinal vein occlusion.Reply: To PMID 25461263.Macular choroidal volume variations in highly myopic eyes with myopic traction maculopathy and choroidal neovascularization.Multimodal Imaging of Vitreoretinal Lymphoma.Choroidal findings in dome-shaped macula in highly myopic eyes: a longitudinal study.Sickle cell maculopathy: Identification of systemic risk factors, and microstructural analysis of individual retinal layers of the macula.Longitudinal modifications of the Ozurdex intravitreal implant as imaged by SD-OCT
P50
Q28085235-B50F3CD3-428F-4D6B-9D66-DF62972A198CQ33584301-0D67062A-7616-489C-AB16-73BD583DDEB8Q33956443-680A2981-969F-4C53-BA2C-20CC2F820E3FQ34036719-07B63752-0DEF-45F8-8A7D-F4765F9941CFQ34325624-163D6941-470B-4620-A96E-78676F7F4AB4Q34667416-99C63961-9926-436B-9F60-9A97102D507AQ34771834-F564A2FE-6B62-4D34-9DFB-A61B89B3FA75Q34774674-8A90CD65-E102-4E1C-94BF-F89CC53EDF32Q35062085-BF5AEEB5-1666-45BA-90AA-D7ED9830D6C4Q35078896-08B44F1F-EEDB-4C46-A662-258235B3245BQ35085778-5449607C-D9B4-4430-858C-503A33A370D7Q36672628-DAE9F59F-7E16-4753-AA0E-EE9054E0BD84Q36718341-B314015D-A7AC-44C0-9192-778A415CDDEEQ37256837-273D5479-C9BE-4DBE-8C68-1CAE0FCA781DQ38596015-5B338432-86F7-4071-B70B-D0597EF9DE2BQ41779524-27B58F5F-C9CC-48F4-8806-66D0466E30B5Q41791287-B4543A62-2F61-4289-A319-9B8BD455ADD1Q43783479-A62E209E-3ECC-4A70-A86B-F6F51C5BE56BQ45164463-6B196999-9D52-4BC8-96F1-4CB15ACFC2DDQ46079822-7EBD8A0A-DC6B-4ADC-BF3A-DFEA70217590Q46093610-7B9B4946-C440-4D0F-A08D-5DBC69AB6B05Q46175352-A09942E3-A99B-44DF-9A8F-13B9DCE55171Q46197626-FB94AB3C-2C3C-49B3-AE40-73FC915DE42CQ46219141-0283392D-6B76-425D-8548-7F3204B4686AQ46226395-22C6471E-FDCC-4663-9830-94EDEB9DF093Q46427401-16B930E2-700A-45D0-81DD-08E75950F94DQ46465055-8392F273-CFF7-4D8D-B95D-E37C456A6A92Q46686208-FB86F37E-EABB-465E-89AE-0FFB505FC483Q46750073-88DD1E0C-E059-48B8-9D74-37A9F74B0212Q46962897-86F8DA7B-1223-4EF6-88C7-6736F85B3CE9Q50219885-663EF245-32CA-4312-8ACC-65105348AAEBQ50449219-83520BAE-CF1E-4B2E-B231-1DFFC19B5172Q55177198-7A58A49B-D34E-4979-A46A-399E95DE8710Q86580815-FB2D0FB3-0149-4D75-B925-D3A23564E326
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Giulio Barteselli
@ast
Giulio Barteselli
@en
Giulio Barteselli
@es
Giulio Barteselli
@sl
type
label
Giulio Barteselli
@ast
Giulio Barteselli
@en
Giulio Barteselli
@es
Giulio Barteselli
@sl
prefLabel
Giulio Barteselli
@ast
Giulio Barteselli
@en
Giulio Barteselli
@es
Giulio Barteselli
@sl
P106
P1153
51863346300
P21
P31
P496
0000-0003-0533-1135